Category Archives: Nanotechnology

C-Bond will work with chemistry and nanotechnology expert Professor Andrew R. Barron, the founder and director of the Energy Safety Research Institute (ESRI) at Swansea University in the UK

HOUSTON, Dec. 09, 2020 (GLOBE NEWSWIRE) -- C-Bond Systems (the Company or C-Bond) (OTC: CBNT), a nanotechnology solutions company, announced today that it is beginning a joint development initiative through a sponsorship agreement with ESRI to enhance C-Bonds glass strengthening products.

Development will be conducted by C-Bonds engineering team and Professor Andrew Barron, the founder and director of the Energy Safety Research Institute (ESRI) at Swansea University in the United Kingdom and the Sr Cymru Chair of Low Carbon Energy and Environment. Prof. Barron is a world renowned chemistry and nanotechnology expert who joined C-Bonds Science Advisory Board in 2019.

The sponsorship will provide the opportunity to work with the institute to improve properties of its glass strengthening products. This agreement allows the C-Bond engineering team access to a world-class research facility, providing capabilities and equipment to further its research efforts.

It is integral for any technology company to continually explore ways to improve its products capabilities and competitive advantages, said Scott R. Silverman, Chairman and CEO of C-Bond. Once again, our in-house engineering team will join forces with Prof. Barron, who we have worked with throughout our history, to enhance our patented glass strengthening products.

Educated at Imperial College (London), Prof. Barron has held posts at the Rice University, University of Texas at Austin, and Harvard. He is the author of over 500 publications, 50 Patents, 8 books, and is the recipient of numerous awards including the Star of Asia International Award, Hmboldt Senior Scientist Research Award, and the first Welch Foundation Norman Hackerman Award.

Prof. Barron is a Fellow of the Royal Society of Chemistry, and in 2009 was appointed as the Prince of Wales Visiting Innovator. In 2011 he won both the Houston Technology Center's Lifetime Achievement Award in Nanotechnology and the World Technology Award for Materials.

The Energy Safety Research Institute is positioned to discover and implement new technology for a sustainable, affordable, and secure energy future and is housed on Swansea Universitys Bay Campus. For more information visit https://www.swansea.ac.uk.

About C-BondC-Bond Systems, Inc. (OTC: CBNT) is a Houston-based advanced nanotechnology company and marketer of the patented C-Bond technology, developed in conjunction with Rice University and independently proven to significantly strengthen glass in key automotive and structural applications. The Companys Transportation Solutions Group sells C-Bond nanoShield, a liquid solution applied directly to automotive windshields, sold through distributors. The Companys Safety Solutions Group sells ballistic-resistant glass solutions directly to private enterprises, schools, hospitals and government agencies. For more information, please visit our website:www.cbondsystems.com, Facebook: https://www.facebook.com/cbondsys/ and Twitter: https://twitter.com/CBond_Systems.

Forward-Looking StatementsStatements in this press release about our future expectations, including the likelihood that development will be conducted by C-Bonds engineering team and Professor Andrew Barron; the likelihood that the sponsorship will provide the opportunity to work with the institute to improve properties of our glass strengthening products; the likelihood that this agreement allows the C-Bond engineering team access to a world-class research facility, providing capabilities and equipment to further our research efforts; the likelihood that our in-house engineering team will join forces with Prof. Barron to enhance our patented glass strengthening products; constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and our actual results could differ materially from expected results. These risks and uncertainties include, without limitation, C-Bonds ability to raise capital; the Companys ability to successfully commercialize its products; the effect of the COVID-19 global pandemic on the Companys ability to operate; as well as other risks. Additional information about these and other factors may be described in the Companys filings with the Securities and Exchange Commission (SEC) including its Form 10-K filed on March 25, 2020, its Forms 10-Q filed on November 16, 2020, August 14, 2020, and May 15, 2020, and in future filings with the SEC. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

Follow ESRI via Twitter @ESRI_Swansea

See more here:
C-Bond Systems Begins Joint Development Initiative with Swansea University to Enhance its Glass Strengthening Products - GlobeNewswire

Hybrid Bonding is an Enabling Process for Heterogeneous IntegrationLeading-edge applications such as artificial intelligence (AI), autonomous driving, augmented/virtual reality (AR/VR) and 5G require the development of high-bandwidth, high-performance and low-power-consumption devices without increasing production cost. As traditional 2D silicon scaling reaches its cost limits, the semiconductor industry is turning to heterogeneous integrationthe manufacturing, assembly and packaging of multiple different components or dies with different feature sizes and materials onto a single device or packagein order to increase performance on new device generations.

Wafer-to-wafer (W2W) hybrid bonding, which involves stacking and electrically connecting wafers from different production lines, is a central process in heterogeneous integration and has a proven track record of success for certain applications such as CMOS image sensors and various memory and logic technologies. However, in cases where the components or dies are not the same size, D2W hybrid bonding offers a viable pathway to enabling heterogeneous integration. With its new D2W bonding solution, extensive experience drawn from its market-leading W2W hybrid bonding solutions and industry collaborations supported by its Heterogeneous Integration Competence Center, EVG is well positioned to support D2W bonding applications.

"For 20 years, EVG has continually set new standards for wafer-to-wafer hybrid and fusion bonding with the largest installed base of wafer bonding solutions worldwide," stated Paul Lindner, executive technology director of EV Group. "We have already begun serving the needs of the emerging die-to-wafer market with a dedicated version of our established EVG GEMINI FB system specially configured for die-to-wafer bonding. The new EVG320 D2W die preparation and activation system adds to our expertise in die-to-wafer bonding and completes EVG's equipment portfolio for providing an end-to-end hybrid bonding solution to accelerate the deployment of 3D/heterogeneous integration. In the future, we anticipate that both wafer-to-wafer and die-to-wafer process flows will be required and run in parallel in numerous fabs for heterogeneous integration applications, providing many opportunities for EVG to support this critical and rapidly growing technology landscape."

Die-to-Wafer Process FlowSeveral different D2W bonding methods are available and are selected depending upon the application and customer requirements. In collective D2W (Co-D2W) bonding, singulated dies are placed on collective die carriers and then are transported to a target wafer for die transfer where a W2W hybrid or fusion bonding system, such as the GEMINI FB, are used to bond the dies to the target wafer. In direct placement D2W (DP-D2W) bonding, the singulated dies are bonded to the target wafer one by one using a pick-and-place flip-chip bonder. Plasma activation and cleaning of the surfaces of the dies on the handler wafer are essential steps for establishing a high-yielding bond and electrical interface between the dies and target wafer. This is where the EVG320 D2W activation system comes in.

Product DetailsThe EVG320 D2W is a highly flexible platform that features a universal hardware/software interface to enable seamless integration with third-party pick-and-place die bonding systems. It also can operate as a stand-alone system depending on integration and line balancing requirements. The system incorporates EVG's advanced cleaning and plasma activation technology, which is available across its industry-standard W2W fusion and hybrid bonding platforms and has been proven in hundreds of installed modules worldwide. In addition, the EVG320 D2W features EVG's alignment verification module (AVM), an integrated metrology module that provides direct feedback to the die bonder on critical process parameters, such as die placement accuracy and die-height information as well as post-bond metrology, for improved process control. Additional features include flexible substrate handling that can accommodate any type of die carrier or film frame that can support plasma activation, hybrid and fusion bonding cleanliness standards, and SECS/GEM standard support.

Product AvailabilityEVG is now accepting orders for the new EVG320 D2W die preparation and activation system, and offering product demonstrations at EVG's Heterogeneous Integration Competence Center at its headquarters in Austria. For more information, please visit https://www.evgroup.com/products/bonding/die-to-wafer-bonding-systems/evg320d2w/.

About EV Group (EVG)EV Group (EVG) is a leading supplier of equipment and process solutions for the manufacture of semiconductors, microelectromechanical systems (MEMS), compound semiconductors, power devices and nanotechnology devices. Key products include wafer bonding, thin-wafer processing, lithography/nanoimprint lithography (NIL) and metrology equipment, as well as photoresist coaters, cleaners and inspection systems. Founded in 1980, EV Group services and supports an elaborate network of global customers and partners all over the world. More information about EVG is available at http://www.EVGroup.com.

Contacts:

Clemens Schtte

David Moreno

Director, Marketing and Communications

Principal

EV Group

Open Sky Communications

Tel: +43 7712 5311 0

Tel: +1.415.519.3915

E-mail: [emailprotected]

E-mail: [emailprotected]

SOURCE EV Group

http://www.EVGroup.com

Originally posted here:
EV Group Unveils Hybrid Die-To-Wafer Bonding Activation Solution To Speed Up Deployment Of 3D Heterogeneous Integration - PRNewswire

(DOUG JESSOPS UTAH SUCCESS STORIES ABC4 NEWS SALT LAKE CITY, UT) Everyone from professional athletes to weekend warriors are looking for a competitive edge. How do you push yourself to peak performance? It takes a lot of practiceand a lot of sweat. A Utah base company has gotten big hydrating the athletic community by going smallnano small.

Adam Legas is no stranger to high level athletics. He had a world record in the decathlon at the age of 12 and was featured in Sports Illustrated. His father was a track coach at BYU. Two of his sons have been college football quarterbacks.

We met at a basketball practice facility and told me the backstory of his passion for combining technology and performance. A number of years ago he went to a conference and met with a group that was using something called nanotechnology to help increase crop yields in agriculture.

What is nanotechnology? In December 1959, Richard Feynman, a well-known American physicist, said in his speech during the meeting of the American Physical Society, What would happen if we could arrange the atoms one by one the way we want them?

An article in ISAAA.ORG put it this way; Nanotechnology refers to controlling, building, and restructuring materials and devices on the scale of atoms and molecules. A nanometer (nm) is one-billionth of a meter. To get the sense of the nano scales, the width of the human hair is 80,000 nm and the smallest things visible with the naked human eye are 10,000 nm across. At nano scales, the basic rules of chemistry and physics are not applicable.One example of this technology is the carbon nanotube discovered in 1991, which is only a few nanometers in diameter but can conduct electricity better than copper; 100 times stronger than steel but only one sixth of its weight. Source: http://www.isaaa.org/resources/publications/pocketk/39/default.asp

Leges has taken that passion for performance as the founder and CEO of Nanohydr8, a sports performance drink. He told me; We take electrolytes, vitamins, minerals, amino acids. that the body needs to perform its best and we make them thousands of times smaller, so they absorb instantly and completely in every cell of the body. and makes you perform the best you possibly can.

Why is absorption important? Leges says that their nanotechnology works rapidly to hydrate the body. There is no digestion necessary. It passes directly through the cell membrane. One trip through the blood stream, which is about forty-five seconds, and youve pretty much got the entire body saturated with electrolytes.

Legass company caught the attention of Coach Dave Houle, the winningest coach in American history. Houle said, He did this research, right away I jumped in and said okay I need to know about this for my athletes. Its like a car. You have to put gas in. you gotta put oil in. If you dont it will eventually break down. So will your body if you dont hydrate, you dont eat properly and dont sleep.

Coach Houle is obviously a fan of the product. He exclaimed; Its the very best sports supplement that you can take every age group. Doesnt matter how old you are. It will help your body hydrate.

While Nanohydr8 bills itself as a sports performance shot for professional and amateur athletes, Legas says his product is for anyone that needs to hydrate. To have total cellular absorption of electrolytes makes every cell connect more effectively. So your thoughts, every muscle contraction, everything in your body works more effectively based on how well your body has absorbed electrolytes.

Nanohydr8 is available nationwide online at http://www.nanohydr8.com and in Utah grocery stores including Maceys, Harmons, Fresh Market, Dans and Lins as well as at Holiday Oil gas stations.

With another Utah Success Story, and Nanohydr8, Im Doug Jessop, ABC4 News

To see more of my Doug Jessops Utah Success Stories go to ABC4.com/Success. If you are a business owner and would like more information on being featured, send me an email at DJessop@abc4.com

This story contains sponsored content

See original here:
Nanotechnology being used to hydrate professional and amateur athletes - WRBL

What is the connection between a sunbed that generates energy from the sun or a bus stop where passengers can charge their mobile phones and a university research laboratory? The answer is Nanotechnology and the Lab for Thin Films Nanobiomaterials Nanosystems & Nanometrology (LTFN) of the Aristotle University of Thessaloniki. LTFN, a world-class excellence entity in various research fields with an experience of more than 25 years in Thin films Technology and the fabrication of advanced nanomaterials and nanoparticles has made a remarkable progress in transforming research into real-life products.

The Nanotechnology Lab LTFN was established in 1991 at the Physics Department of Aristotle University of Thessaloniki with the aim to promote world-class research and best-practices in Nanotechnology, Organic Electronics, Nanomedicine and Nanometrology in order to address global challenges in Manufacturing, Energy, Lighting, Electronics, Photonics, Internet of Things (IoT), Transportation, Health and Quality of Life, Agriculture, etc.

Embracing the need to connect academic research with industrial applications and the business world, the Laboratory has been operating as a Digital Innovation Hub providing open access to interested entities (Academia, Research, SMEs, Industries), while serving as a One-Stop-Shop for SMEs for technology transfer, proof-of-concept and incubation under the direction of Professor Stergios Logothetidis.

Within this scope, the LTFN has founded HOPE A, the Hellenic Organic & Printed Electronics Association that organizes and co-ordinates the activities of industrial and research institutions in Greece in the field of Organic & Printed Electronics. The term Organic & Printed Electronics refers to a process in which printing technology is used to produce various kinds of electronic goods such as electronic circuits, displays, sensors etc. using materials constructed from organic (carbon-based) molecules or polymers. As scientists explain, this technology means that the electronics that are produced offer high mechanical flexibility and high thermal stability in low cost, compared to traditional electronics. HOPE-A counting more than 40 participating companies has signed cooperation agreements with innovation clusters from around the world, while participating as partner in research projects that aim to create innovative products that will be transferred to the market.

In Greece such innovative products are already being produced by the Organic Electronics Technologies (OET), a company originated at the Aristotle University of Thessaloniki, the only company in this sector in the country and one of the few in the world. The company is producing third-generation photovoltaics, organic photovoltaic (OPV) solar cells covering greenhouses and being utilized in heating and cooling systems. These photovoltaic panels are mainly intended for faades contributing to the energy efficiency of buildings, while offering design solutions as they are semitransparent and come in different colors.

Flexible solar panels can be bent and folded and as a result they can have multiple uses. OET has already produced a smart bus stop which is autonomous in energy terms thanks to the printable organic photovoltaics that cover the curved dome of the stand, producing energy from diffuse light. This smart bus stop gives passengers the opportunity to charge their mobile phone while they are waiting for their bus to arrive protecting them at the same time from the UV sun rays. The stop is also autonomously illuminated at night thanks to LED lighting, while additional services such as free Wi-Fi connection can be offered.

READ MORE:Greek government calls on diaspora to invest in Greece, but not just for sentimental reasons

The Municipality of Neapoli-Sykies in Thessaloniki has already placed a smart bus stop using nanotechnology as part of a development program that finances and promotes the creation of smart-cities in the Greek regions limiting the emission of carbon dioxide and multiplying the social benefit for citizens.

Apart from the smart bus stop, OET has created sun loungers and sunbeds equipped with flexible photovoltaic films offering shading and energy at the same time. With built-in USB ports, users can charge their mobile phone or tablet while enjoying iced water, soft drinks or wine kept in a small refrigerator. The same recyclable nanotechnology is also used in awnings and pergolas providing simultaneously shading and green energy. OET has also fitted its third-generation photovoltaics on the roof of an electric car covering up to the 15% of the needed energy, without neglecting the application of Organic Printed Photovoltaics on clothing for warming or producing electricity.

The Laboratory of Nanotechnology has also founded a Nanomedical company, the BL Nanobiomed that has been dealing with the optimization of medical products through Nanotechnology. The aim of the company is to develop novel nanomedical technologies and products in order to overcome the clinical hurdles in the prevention, diagnosis and therapy of diseases such as nanoparticles for targeted therapeutics, antimicrobial, biosensing activities and nanofilters. After the outbreak of the COVID-19 pandemic, BL Nanobiomed created a nanofilter for advanced filtration of face masks at nanoscale that protects 99 per cent against the coronavirus having also the ability to adapt to any type of mask. The company is also working on a cosmetic nano-formula with antioxidants for skin-regeneration purpose.

The Lab is working on a variety of applications linked to several research fields that could be summarized in the following list:

Organic Electronics: OLEDs for displays and lighting, OPVs, OTFTs, sensors RFID Energy: OPVs for electricity generation, OLED lighting for energy efficiency Wearables: smart textiles with energy and lighting functionalities Buildings: energy efficient buildings, lighting, tents, roofs Automotive: energy generation and autonomy, solar roofs Agriculture: energy efficient Mediterranean Green-houses by OPVs & OLEDs Smart Packaging: food, consumer products, pharmaceutical products Nanomedicine: stents, orthopaedic implants, contact lenses, biosensors etc. Information Technology: Organic Electronics, Micro- electronics, Optoelectronics and Optics, Storage and Displays, Micro fabrication

READ MORE:Greek Australian business people interested in investment opportunities in Greece

LTFN has developed strong collaborations with numerous education and research institutes in Europe, USA and Asia, while continues networking and partnership with key players from academia and industry worldwide. Through its participation to EU funding programs in recent years, LTFN has managed to improve its nano-production methods and more precisely to produce certain smart nanomaterials, develop smart technologies and construct suitable machines and tools. Through its state-of-the-art infrastructure and most importantly through the creation of manufacturing pilot lines the Lab is in a position to produce a series of innovative products such as printed organic photovoltaics etc.

LTFN also coordinates the Research & Innovation Network Nano|Net, two Post Graduate Programs on Nanosciences and Nanotechnologies NN, while it organizes annually the internationally established NANOTEXNOLOGY multi-event that combines International Conferences, Summer Schools and Exhibitions on Nanotechnology, Organic Electronics and Nanomedicine.

According to Professor Logothetidis the Laboratory is currently coordinating five major European research and development projects collaborating with the largest companies and research centers in the world in order to build applications mainly in the field of organic. At the same time, eight other national programs are underway involving more than 40 universities, research institutes and innovation companies. 35 researchers are currently working in the Lab that is also attracting scientists from foreign countries contributing to the reverse of Brain Drain to Brain Gain. The Lab will also participate in the Thess-INTEC mega project, the International Technology Center in Thessaloniki that is under development and aims to enhance innovative partnerships between research and industrial actors.

READ MORE:Microsofts $1 billion investment set to accelerate Greeces digital transformation

Source: Greek News Agenda

Continued here:
The fascinating world of nanotechnology and the LTFN lab of Aristotle University - Neos Kosmos

About a decade ago, I was at an all-day symposium at a university in Lahore. The chief guest was the head of a national agency in charge of nanotechnology. In his speech, he talked about why nanotechnology was the future, and since Pakistanis are bright, the future of nanotechnology was bright in Pakistan. The dean of the institution hosting the seminar, an accomplished electrical engineer and a global leader in his field, spoke right after the chief guest and asked a simple question. Can Pakistan be the leader in nanotechnology when we are nowhere on the map with microtechnology? If our fundamentals remain weak and disjointed, can we expect to lead the world in the next biggest thing?

The question, of course, was rhetorical, but one that troubled the chief guest who had not expected anything but thunderous applause. He didnt have an answer except the empty promise that Pakistan will be the hub of nanotechnology in the next decade.

That decade passed some time ago, and nothing has changed. Not because people are not capable, but because global leadership doesnt come from hollow slogans and empty promises, but through dedicated efforts of individuals and institutions built on solid foundations. What we havent learned is that the vision for science, technology, medicine or engineering cannot be based on bombastic documents, or over-the-top predictions but by meticulous work to get the basic foundation in place. Some of that work may seem boring, and not cutting edge, but is absolutely critical for any future development. Cutting edge technology doesnt come from thin air, neither does it work in a vacuum.

The utterly tragic incident in Peshawar over the weekend where a number of patients died because of lack of oxygen is a case in point. We are well past the point of having anyone take real responsibility that just doesnt happen anymore, whether people die in hospitals due to negligence or in trains. I wouldnt be surprised if in some warped statement some official blames the patient in the ICU. When it comes to responsibility, we have done much worse before.

To say that it was unacceptable is an understatement. What is even more troubling is that at a time of a national health emergency, our systems should be more robust not less so. If this can happen at one of the major hospitals, in a provincial capital, makes one worry about smaller towns and less resourced hospitals.

But there is a bigger point here. We should recognise that we have to get the basics right. And they are not right at the moment. While utterly tragic, this is not an isolated incident and shouldnt be thought so either. Our basic building blocks, of rigour, regulation and quality control are either not in place, or if they are, they are not functioning the way they should. Whether we are aiming for the moon, or saving a vulnerable life, we have to demonstrate quality control, secure the supply chain, and create a system that is resilient against negligence and human error. With a massive vaccination campaign right around the corner, we cannot let the entire system crumble because we did not get the basics right.

There is absolutely nothing wrong with aiming high and perhaps we all ought to do so. But we are likely to fall flat, and in doing so, hurt a lot of people if we do not get the fundamentals in place. We cannot continue to jump on the next bandwagon because it is now the coolest thing out there. We have to weave and stich, lest in our desire to have the fanciest dress, we may soon realise that we have no clothes.

Published in The Express Tribune, December 8th, 2020.

Like Opinion & Editorial on Facebook, follow @ETOpEd on Twitter to receive all updates on all our daily pieces.

More:
Getting the basics right - The Express Tribune

Nanotechnology has contributed to the production of vaccines against the COVID-19 virus. However, in Europe, a de-centralised and vague regulatory framework prevents nanomedicines from harnessing their full potential to save lives.

At a recent event organised by the European Alliance for Access to Safe Medicines (EAASM), EU lawmakers and stakeholders focused on nanomedicines, which are emerging as an innovative technology in the scientific field, as they help address unmet medical needs and offer alternatives for many therapeutic areas.

Nanomedicine uses state-of-the-art nanotechnology like nanoparticles, nanorobots or nanoelectronic biosensors for diagnosing or treating cancer, cardiovascular, and neurodegenerative diseases.

The pharma industry has mounted the pressure on the European Commission to play a more active role when it comes to nanomedicines. The EU executive recently published its new Pharmaceutical Strategy, in which the push for innovation is taking centre stage.

Under affordability and access to medicines, there is a quite a big push for boosting medicines that basically respond to unmet needs, Anthony Rodiadis from the European Commissions DG SANTE commented.

However, a number of issues related to the regulatory framework raise more questions than answers while critics suggest that without an EU-centralised approach, the potential of nanomedicines will remain untapped.

In addition, at present, there is no specific regulatory pathway for follow-on nanosimilars. Given their highly complex manufacturing process, it is possible that even the slightest change from the original nanomedicine would result in a different level of efficacy.

Maria da Graa Carvalho, a Portuguese MEP from the European Peoples Party (EPP), emphasised the potential of nanomedicines in delivering unmet medical needs but noted that the current regulatory framework puts severe obstacles on the process.

We may conclude that the practical translation into treatments has not progressed as quickly as we would like to and as the enormous positive preclinical results have suggested. We are convinced that the reason for this is that we do not have a strong fit-for-purpose regulatory framework, the centre-right EU lawmaker said.

Nanotechnology and COVID-19

Jon De Vlieger, director of business development at Lygature, a not-for-profit partnership management provider bringing together academia, industry and society, said nanomedicines are already being provided to patients saving lives every day.

He added that two of the front runner vaccines for COVID-19, Pfizer and Moderna, which the European Medicines Agency is expected to approve on 29 December and 12 January respectively, do include nanotechnology-based approaches.

Both vaccines are based on lipid-based nanoparticles. So, its important to realise that it has a huge opportunity, its already established, but there are still some challenges that we need to solve, he said.

There are different procedures to authorise a medicine in Europe: mainly the centralised and the de-centralised processes. In the centralised procedure, the European Medicines Agency (EMA) conducts its own scientific studies, and then the European Commission gives the green light for market authorisation. The Commissions decision is valid in all EU member states.

On the other hand, the de-centralised procedure is used for authorising medicines in more than one EU member states in parallel. According to EMA, it can be used for medicines that do not need to be authorised via the centralised procedure and have not already been authorised in any member state.

Nanomedicines are by nature complex and things become even more complicated due to the lack of a centralised approach: currently, regulatory authorities at the member state level assess them differently.

De Vlieger presented a study on 85 different nanomedicines applications. Just two of these products were approved through the centralised procedure.

He explained that a centralised process should be the best route for nanomedicines as it guarantees consistency in the scientific evaluation of these products, and centralised safety monitoring.

Visit link:
Nanotechnology: Part of COVID-19 vaccines but potential still hindered in Europe - EURACTIV